Adlai Nortye ANL
NASDAQ ANL
$15.01 +0.26 (+1.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Cash & Current Investments (2022 - 2026)

Adlai Nortye (ANL) posted quarterly Cash & Current Investments of $8.1 million for Q4 2025, down 86.77% year-over-year from $60.9 million in Q4 2024, and down 81.75% quarter-over-quarter from $44.1 million in Q2 2025.

Analysis

Adlai Nortye (ANL) Cash & Current Investments (2022 - 2026) Analysis & Trends

Adlai Nortye (ANL) has reported Cash & Current Investments for 4 consecutive years, with $8.1 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Cash & Current Investments fell 86.77% year-over-year to $8.1 million; the TTM figure through Dec 2025 stood at $8.1 million (down 86.77% YoY), while the FY2025 annual figure was $8.1 million, down 86.77% from the prior year.
  • Cash & Current Investments fell to $8.1 million in Q4 2025 per ANL's latest filing, from $44.1 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $98.0 million in Q2 2024 and bottomed at $8.1 million in Q4 2025.
  • Historically, Cash & Current Investments has averaged $61.1 million across 4 years, with a median of $62.5 million in 2022.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments surged 42.87% — and 2025, when it sank 86.77%.
  • Adlai Nortye's Cash & Current Investments stood at $64.0 million in 2022, then soared by 42.87% to $91.5 million in 2023, then tumbled by 33.43% to $60.9 million in 2024, then tumbled by 86.77% to $8.1 million in 2025.
  • Business Quant data shows ANL's Cash & Current Investments at $8.1 million in Q4 2025, $44.1 million in Q2 2025, and $60.9 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 Adlai Nortye 500.08 Mn 268.19 Mn - 231.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 231.89 Mn
Dec 31, 2025 8.06 Mn
Jun 30, 2025 44.15 Mn
Dec 31, 2024 60.91 Mn
Jun 30, 2024 97.99 Mn
Dec 31, 2023 98.49 Mn
Dec 31, 2022 64.05 Mn